文献速递前列腺癌

保留Retzius间隙与前入路机器人辅助根治性前列腺切除术的长期肿瘤学结局:随机队列的事后分析

Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort.
PubMed 文献 · Eur Urol Oncol · 2026-09-05

本研究为随机对照试验的事后分析,纳入120例低至中危前列腺癌患者,1:1随机接受保留Retzius间隙(RS)或前入路机器人辅助根治性前列腺切除术。中位随访77个月,5年无进展生存率RS组80.2% vs 前入路组91.1%(p=0.01);校正CAPRA-S评分后,RS组疾病进展风险为前入路组的2.64倍(p=0.049)。结论认为RS入路虽早期控尿更优,但长期肿瘤学控制较差。

要点

  • 5年无进展生存率RS组80.2%低于前入路组91.1%(p=0.01)。
  • 校正CAPRA-S评分后,RS组进展风险为前入路组的2.64倍(p=0.049)。
  • RS入路早期控尿优势可能以长期肿瘤学控制为代价。

核心结论

  • RS入路RARP虽提供更优的早期控尿结局,但随机接受该入路的患者长期肿瘤学控制较差,可能与手术技术难度增加有关。

研究设计与样本

  • 随机对照试验的事后分析,共纳入120例40-75岁低至中危前列腺癌患者,1:1随机分为前入路组和RS组(每组n=60),均在三级转诊中心接受RARP。

主要发现

  • 中位随访77个月(四分位距30-110),5年无进展生存率RS组为80.2%,前入路组为91.1%(p=0.01)。
  • 校正CAPRA-S评分后,RS组疾病进展风险为前入路组的2.64倍(p=0.049)。

临床怎么用

  • 对于低至中危前列腺癌患者,选择RS入路RARP时需权衡早期控尿获益与长期肿瘤学风险,并考虑术者技术经验。

局限性

  • 原研究设计未将长期肿瘤学结局作为主要终点。
  • 术者此前对RS入路经验有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The Retzius-sparing (RS) robot-assisted radical prostatectomy (RARP) was proposed in 2010 to enhance early postoperative continence recovery. However, long-term oncological outcomes following this approach remain insufficiently characterized. This study reports the long-term oncological outcomes of a randomized controlled trial originally designed to compare early continence recovery in patients treated using the RS versus standard (anterior) approach. DESIGN, SETTING, PARTICIPATNS AND INTERVENTION: A total of 120 men aged 40-75 yr with low- to intermediate-risk prostate cancer underwent RARP at a tertiary referral center. Patients were randomized 1:1 to the anterior or RS approach (n = 60 per arm). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary end point was progression-free survival (PFS), defined as biochemical recurrence and/or the need for any additional treatment. Kaplan-Meier plots were used to depict and compare PFS between the approaches. Cox regression was used to examine the impact of the approach on PFS after adjusting for the Cancer of the Prostate Risk Assessment Postsurgical (CAPRA-S) scores. RESULTS AND LIMITATIONS: Median follow-up was 77 mo (interquartile range 30-110). At 5 yr, PFS was 80.2% in the RS group versus 91.1% in the anterior group (p = 0.01). After adjusting for CAPRA-S score, patients undergoing the RS approach were 2.64-fold more likely to experience progression (p = 0.049). The main limitations of this study stem from its original design, which did not consider long-term oncological outcomes as a primary end point, and from surgeons' limited prior experience with the RS approach. CONCLUSIONS: Although RS RARP provides superior early continence outcomes, patients randomized to this approach experienced less favorable long-term oncological control, potentially because of the increased technical demands of the procedure.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Santangelo A, Jeong W, Silvani C, et al. Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort. Eur Urol Oncol. 2026. PMID: 42697825. doi:10.1016/j.euo.2026.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。